Maász, A.; Bodó, T.; Till, Á.; Molnár, G.; Masszi, G.; Labossa, G.; Herbert, Z.; Bene, J.; Hadzsiev, K.
Three-Year Follow-Up after Intrauterine mTOR Inhibitor Administration for Fetus with TSC-Associated Rhabdomyoma. Int. J. Mol. Sci. 2023, 24, 12886.
https://doi.org/10.3390/ijms241612886
AMA Style
Maász A, Bodó T, Till Á, Molnár G, Masszi G, Labossa G, Herbert Z, Bene J, Hadzsiev K.
Three-Year Follow-Up after Intrauterine mTOR Inhibitor Administration for Fetus with TSC-Associated Rhabdomyoma. International Journal of Molecular Sciences. 2023; 24(16):12886.
https://doi.org/10.3390/ijms241612886
Chicago/Turabian Style
Maász, Anita, Tímea Bodó, Ágnes Till, Gábor Molnár, György Masszi, Gusztáv Labossa, Zsuzsanna Herbert, Judit Bene, and Kinga Hadzsiev.
2023. "Three-Year Follow-Up after Intrauterine mTOR Inhibitor Administration for Fetus with TSC-Associated Rhabdomyoma" International Journal of Molecular Sciences 24, no. 16: 12886.
https://doi.org/10.3390/ijms241612886
APA Style
Maász, A., Bodó, T., Till, Á., Molnár, G., Masszi, G., Labossa, G., Herbert, Z., Bene, J., & Hadzsiev, K.
(2023). Three-Year Follow-Up after Intrauterine mTOR Inhibitor Administration for Fetus with TSC-Associated Rhabdomyoma. International Journal of Molecular Sciences, 24(16), 12886.
https://doi.org/10.3390/ijms241612886
